DEXCOM INC | 2012 | FY | 3


3. Financial Statement Details (in millions)

Short-Term Marketable Securities, Available for Sale

As of December 31, 2012, we had no investments that were in significant unrealized loss position. Short-term investment securities, consisting solely of debt securities with contractual maturities of less than one year, were as follows:

 

     December 31, 2012  
     Amortized
Cost
     Gross
Unrealized
Gains
     Gross
Unrealized
Losses
     Estimated
Market
Value
 

U.S. government agencies

   $ 31.8       $ 0.0       $ 0.0       $ 31.8   

Commercial paper

     0.8         0.0         0.0         0.8   

Corporate debt

     8.0         0.0         0.0         8.0   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 40.6       $ 0.0       $ 0.0       $ 40.6   
  

 

 

    

 

 

    

 

 

    

 

 

 

 

     December 31, 2011  
     Amortized
Cost
     Gross
Unrealized
Gains
     Gross
Unrealized
Losses
     Estimated
Market
Value
 

U.S. government agencies

   $ 61.9       $ 0.0       $ 0.0       $ 61.9   

Commercial paper

     7.5         0.0         0.0         7.5   

Corporate debt

     10.0         0.0         0.0         10.0   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 79.4       $ 0.0       $ 0.0       $ 79.4   
  

 

 

    

 

 

    

 

 

    

 

 

 

Accounts Receivable

 

     December 31,  
     2012     2011  

Accounts receivable

   $ 20.7      $ 13.2   

Less allowance for doubtful accounts, sales returns and discounts

     (1.2     (0.7
  

 

 

   

 

 

 

Total

   $ 19.5      $ 12.5   
  

 

 

   

 

 

 

 

Inventory

 

     December 31,  
     2012      2011  

Raw materials

   $ 2.5       $ 4.6   

Work in process

     0.4         0.6   

Finished goods

     4.5         3.0   
  

 

 

    

 

 

 

Total

   $ 7.4       $ 8.2   
  

 

 

    

 

 

 

Property and Equipment

 

     December 31,  
     2012     2011  

Furniture and fixtures

   $ 2.5      $ 2.4   

Computer equipment

     12.0        9.2   

Machinery and equipment

     16.2        12.9   

Leasehold improvements

     9.3        7.0   
  

 

 

   

 

 

 

Total

     40.0        31.5   

Accumulated depreciation and amortization

     (21.1     (16.5
  

 

 

   

 

 

 

Property and equipment, net

   $ 18.9      $ 15.0   
  

 

 

   

 

 

 

Depreciation and amortization expense related to property and equipment for the years ended December 31, 2012, 2011, and 2010 was $6.1 million, $3.8 million, and $2.4 million, respectively.

Goodwill and Intangible Assets

Goodwill and intangible assets as of December 31, 2012 consisted of the following (in millions, except months):

 

     Weighted-Average
Amortization Period
(in months)
     Gross
Amount
     Accumulated
Amortization
    Intangible Assets, net  

Intangible assets subject to amortization

          

Developed technology

     109       $ 3.2       $ (0.3   $ 2.9   

Customer-related intangible

     70         0.6         (0.1     0.5   

Covenants not-to-compete

     70         0.6         (0.1     0.5   
     

 

 

    

 

 

   

 

 

 

Total

      $ 4.4       $ (0.5   $ 3.9   
     

 

 

    

 

 

   

 

 

 

Intangible assets not subject to amortization

          

In-process research and development

             0.2   

Trademarks and trade names

             0.1   

Goodwill

             3.2   
          

 

 

 

Total

           $ 3.5   
          

 

 

 

Total expense related to amortization of intangible assets was $0.5 million for the year ended December 31, 2012, compared to none for each of the same periods in 2011 and 2010.

 

The following table sets forth the total future amortization expense related to intangible assets subject to amortization as of December 31, 2012:

 

Fiscal Year Ending

  

2013

   $ 0.6   

2014

     0.6   

2015

     0.6   

2016

     0.5   

2017

     0.5   

Thereafter through 2021

     1.1   
  

 

 

 

Total

   $ 3.9   
  

 

 

 

Accounts Payable and Accrued Liabilities

 

     December 31,  
     2012      2011  

Accounts payable trade

   $ 3.9       $ 2.8   

Accrued tax, audit, and legal fees

     0.7         0.7   

Clinical trials

     0.1         0.2   

Accrued other including warranty

     2.8         2.6   

Acquisition-related liabilities

     1.2         0.0   
  

 

 

    

 

 

 

Total

   $ 8.7       $ 6.3   
  

 

 

    

 

 

 

Accrued Payroll and Related Expenses

 

     December 31,  
     2012      2011  

Accrued paid time off

   $ 2.3       $ 1.9   

Accrued wages, bonus and taxes

     6.1         4.3   

Other accrued employee benefits

     0.8         0.6   
  

 

 

    

 

 

 

Total

   $ 9.2       $ 6.8   
  

 

 

    

 

 

 

Accrued Warranty

 

     Year Ended December 31,  
         2012             2011      

Beginning balance

   $ 0.3      $ 0.4   

Charges to costs and expenses

     1.9        1.8   

Costs incurred

     (1.9     (1.9
  

 

 

   

 

 

 

Ending balance

   $ 0.3      $ 0.3   
  

 

 

   

 

 

 

us-gaap:AdditionalFinancialInformationDisclosureTextBlock